Trial Profile
Gonadotropin-releasing Hormone (GnRH) Downregulation Versus Oral Anticonception Prior to ART in Postoperative Endometriosis Patients
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary) ; Ethinylestradiol/dienogest
- Indications Endometriosis
- Focus Therapeutic Use
- Acronyms ultra-long study; Ultralong Study
- 24 Apr 2018 Status has been changed to discontinued.
- 08 Nov 2017 Status changed from recruiting to completed.
- 04 Sep 2014 New trial record